CDT
Conduit Pharmaceuticals Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website conduitpharma.com
- Employees(FY) -
- ISIN US20678X1063
Performance
-2.3%
1W
-3.88%
1M
-0.67%
3M
+153.67%
6M
-34.73%
YTD
-71.71%
1Y
Profile
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
Technical Analysis of CDT 2024-05-10
Overview:
In analyzing the technical indicators for CDT stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for potenti...
Recent News & Updates
- 2024-05-14 21:53
- 2024-03-18 22:57
Conduit Pharmaceuticals Adds Key Leadership Positions(Yahoo Finance)
- 2024-03-18 19:00
- 2024-03-11 02:26
Conduit Pharmaceuticals Opens New Laboratory in UK(Yahoo Finance)
- 2024-03-10 19:00
- 2024-01-30 19:30
- 2023-11-01 20:30
- 2023-10-29 20:39
Why Is Conduit Pharmaceuticals (CDT) Stock Up 66% Today?(Investorplace)
- 2023-10-10 20:30
- 2023-10-05 21:29
- 2023-10-05 20:30
- 2023-09-21 21:01
- 2023-09-20 05:40
- 2023-09-12 20:30
- 2023-09-07 04:30
- 2023-08-31 04:05
- 2023-08-15 20:30
Page 1 of 1
previousnext